Article 11 CTR PL

Running trials

• Not yet recruiting

  NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer

  NCT07178730· Phase 3· Source

• Enrolling by invitation

  SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

  NCT07141329· Phase 2· Source

• Recruiting

  A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

  NCT07699328· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy1 recruiting
• Lung cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.